Taysha Gene Therapies Financial Overview
Taysha Gene Therapies's market cap is currently $1.38B. The company's EPS TTM is $-0.09; its P/E ratio is ―; Taysha Gene Therapies is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
